Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (51)
Kimberly Y. Kartowikromo, Orobola E. Olajide & Ahmed M. Hamid. (2023) Collision cross section measurement and prediction methods in omics. Journal of Mass Spectrometry.
Crossref
Crossref
Suhair Mohammed Yousuf, Ahmad Maaen Alater, Majid Alabdulla & Mugtaba Osman. (2023) False Positive Tramadol Urine Testing in Patients Taking Fexofenadine: A Tale of Two Consecutive Cases. Case Reports in Psychiatry 2023, pages 1-4.
Crossref
Crossref
Olaf H. Drummer & Dimitri Gerostamoulos. 2022. Handbook of Forensic Medicine. Handbook of Forensic Medicine
1129
1136
.
Olivier Salamin, Arnaud Garcia, Víctor González‐Ruiz, Francesca Rossi, Xavier Bigard, Julien Déglon, Youssef Daali, Raphaël Faiss, Martial Saugy & Serge Rudaz. (2020) Is pain temporary and glory forever? Detection of tramadol using dried blood spot in cycling competitions. Drug Testing and Analysis 12:11-12, pages 1649-1657.
Crossref
Crossref
Adam Borik, Andrea Vojs Staňová, Bryan W. Brooks, Kateřina Grabicová, Tomáš Randák & Roman Grabic. (2020) Determination of citalopram in fish brain tissue: benefits of coupling laser diode thermal desorption with low- and high-resolution mass spectrometry. Analytical and Bioanalytical Chemistry 412:18, pages 4353-4361.
Crossref
Crossref
Hans H. Maurer. (2020) Pitfalls in drug testing by hyphenated low‐ and high‐resolution mass spectrometry. Drug Testing and Analysis 12:2, pages 172-179.
Crossref
Crossref
A. Zara Herskovits, David J. Kemble & Lynne Uhl. (2020) Approaches to drug monitoring: partnering with the clinical laboratory. International Anesthesiology Clinics 58:2, pages 12-18.
Crossref
Crossref
Michael Fagiola. (2019) Current and future directions of high resolution and tandem mass spectrometry in postmortem and human performance toxicology. Legal Medicine 37, pages 86-94.
Crossref
Crossref
Maarten Degreef, Alexander L.N. van Nuijs & Kristof E. Maudens. (2018) Validation of a simple, fast liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of 40 antidepressant drugs or their metabolites in plasma. Clinica Chimica Acta 485, pages 243-257.
Crossref
Crossref
Darlington Danso, Loralie J Langman & Paul J Jannetto. (2018) Interference Testing and Isobaric Compounds: Is Your Mass Spectrometry-based Assay as Good as You Think It Is?. The Journal of Applied Laboratory Medicine 2:4, pages 666-668.
Crossref
Crossref
Ana Celia Muñoz-Muñoz, Teresa Pekol, Dana Schubring, Charlene Johnson & Lawrence Andrade. (2018) Identification of Novel Opioid Interferences using High-Resolution Mass Spectrometry†. Journal of Analytical Toxicology 42:1, pages 6-16.
Crossref
Crossref
Julian A. Michely & Hans H. Maurer. (2018) A multi-analyte approach to help in assessing the severity of acute poisonings - Development and validation of a fast LC-MS/MS quantification approach for 45 drugs and their relevant metabolites with one-point calibration. Drug Testing and Analysis 10:1, pages 164-176.
Crossref
Crossref
Amedeo De Nicolò, Marco Cantù & Antonio D'Avolio. (2017) Matrix effect management in liquid chromatography mass spectrometry: the internal standard normalized matrix effect. Bioanalysis 9:14, pages 1093-1105.
Crossref
Crossref
Wilfried M. A. Niessen & Ricardo A. Correa C.. 2017. Interpretation of MS‐MS Mass Spectra of Drugs and Pesticides. Interpretation of MS‐MS Mass Spectra of Drugs and Pesticides
129
349
.
Maria Shipkova & Dobrin Svinarov. (2016) LC–MS/MS as a tool for TDM services: Where are we?. Clinical Biochemistry 49:13-14, pages 1009-1023.
Crossref
Crossref
Daniela Remane, Diana Wetzel & Frank T. Peters. (2014) Development and validation of a liquid chromatography-tandem mass spectrometry (LC-MS/MS) procedure for screening of urine specimens for 100 analytes relevant in drug-facilitated crime (DFC). Analytical and Bioanalytical Chemistry 406:18, pages 4411-4424.
Crossref
Crossref
Olaf H. Drummer & Dimitri Gerostamoulos. 2014. Handbook of Forensic Medicine. Handbook of Forensic Medicine
866
872
.
Huei-Ru Lin, Ka-Ian Choi, Tzu-Chieh Lin & Anren Hu. (2013) Simultaneous quantification of amphetamine, opiates, ketamine and relative metabolites in urine for confirmatory analysis by liquid chromatography tandem mass spectrometry. Journal of Chromatography B 929, pages 133-141.
Crossref
Crossref
Hans H. Maurer. (2013) What is the future of (ultra) high performance liquid chromatography coupled to low and high resolution mass spectrometry for toxicological drug screening?. Journal of Chromatography A 1292, pages 19-24.
Crossref
Crossref
Andrea Bo?ovi?Vathany Kulasingam. (2013) Quantitative mass spectrometry-based assay development and validation: From small molecules to proteins. Clinical Biochemistry 46:6, pages 444-455.
Crossref
Crossref
Marie Kj?rgaard Bj?rk, Kirsten Wiese Simonsen, David Wederkinck Andersen, Petur Weihe Dalsgaard, Stella R?gn Sigur?ard?ttir, Kristian Linnet & Brian Schou Rasmussen. (2013) Quantification of 31 illicit and medicinal drugs and metabolites in whole blood by fully automated solid-phase extraction and ultra-performance liquid chromatography?tandem mass spectrometry. Analytical and Bioanalytical Chemistry 405:8, pages 2607-2617.
Crossref
Crossref
Eva Saar, Jochen Beyer, Dimitri Gerostamoulos & Olaf H. Drummer. (2012) The analysis of antipsychotic drugs in human matrices using LC‐MS(/MS). Drug Testing and Analysis 4:6, pages 376-394.
Crossref
Crossref
Josephine Ruta, Julien Boccard, Deirdre Cabooter, Serge Rudaz, Gert Desmet, Jean-Luc Veuthey & Davy Guillarme. (2012) Method development for pharmaceutics: Some solutions for tuning selectivity in reversed phase and hydrophilic interaction liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis 63, pages 95-105.
Crossref
Crossref
Ruth Verplaetse & Jan Tytgat. (2012) Development and validation of a sensitive UPLC?MS/MS method for the analysis of narcotic analgesics in urine and whole blood in forensic context. Forensic Science International 215:1-3, pages 136-145.
Crossref
Crossref
Maria Kingbäck, Louise Karlsson, Anna-Lena Zackrisson, Björn Carlsson, Martin Josefsson, Finn Bengtsson, Johan Ahlner & Fredrik C. Kugelberg. (2012) Influence of CYP2D6 genotype on the disposition of the enantiomers of venlafaxine and its major metabolites in postmortem femoral blood. Forensic Science International 214:1-3, pages 124-134.
Crossref
Crossref
Catherine Hammett-Stabler & Steven W. Cotten. 2012. LC-MS in Drug Analysis. LC-MS in Drug Analysis
1
13
.
Christoph Seger & Michael Vogeser. 2012. LC-MS in Drug Bioanalysis. LC-MS in Drug Bioanalysis
109
126
.
W.M.A. Niessen. (2011) Fragmentation of toxicologically relevant drugs in positive-ion liquid chromatography-tandem mass spectrometry. Mass Spectrometry Reviews 30:4, pages 626-663.
Crossref
Crossref
J?rgen Hasselstr?m. (2011) Quantification of antidepressants and antipsychotics in human serum by precipitation and ultra high pressure liquid chromatography?tandem mass spectrometry. Journal of Chromatography B 879:1, pages 123-128.
Crossref
Crossref
V. Viette, D. Guillarme, R. Mylonas, Y. Mauron, M. Fathi, S. Rudaz, D. Hochstrasser & J.-L. Veuthey. (2011) A multi-target screening analysis in human plasma using fast liquid chromatography?hybrid tandem mass spectrometry (Part I). Clinical Biochemistry 44:1, pages 32-44.
Crossref
Crossref
Lewis Couchman & Phillip E. Morgan. (2010) LC‐MS in analytical toxicology: some practical considerations. Biomedical Chromatography 25:1-2, pages 100-123.
Crossref
Crossref
Marta Concheiro, Teresa R. Gray, Diaa M. Shakleya & Marilyn A. Huestis. (2010) High-throughput simultaneous analysis of buprenorphine, methadone, cocaine, opiates, nicotine, and metabolites in oral fluid by liquid chromatography tandem mass spectrometry. Analytical and Bioanalytical Chemistry 398:2, pages 915-924.
Crossref
Crossref
Michael Vogeser & Christoph Seger. (2010) Pitfalls Associated with the Use of Liquid Chromatography–Tandem Mass Spectrometry in the Clinical Laboratory. Clinical Chemistry 56:8, pages 1234-1244.
Crossref
Crossref
Hans H Maurer. (2010) Perspectives of Liquid Chromatography Coupled to Low- and High-Resolution Mass Spectrometry for Screening, Identification, and Quantification of Drugs in Clinical and Forensic Toxicology. Therapeutic Drug Monitoring 32:3, pages 324-327.
Crossref
Crossref
Elli Tyrkkö, Anna Pelander & Ilkka Ojanperä. (2010) Differentiation of structural isomers in a target drug database by LC/Q‐TOFMS using fragmentation prediction. Drug Testing and Analysis 2:6, pages 259-270.
Crossref
Crossref
Marie Kjærgaard Bjørk, Marie K. K. Nielsen, Lotte Ø. Markussen, Helene B. Klinke & Kristian Linnet. (2009) Determination of 19 drugs of abuse and metabolites in whole blood by high-performance liquid chromatography–tandem mass spectrometry. Analytical and Bioanalytical Chemistry 396:7, pages 2393-2401.
Crossref
Crossref
Sarah J Glover & Keith R Allen. (2009) Measurement of benzodiazepines in urine by liquid chromatography-tandem mass spectrometry: confirmation of samples screened by immunoassay. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 47:2, pages 111-117.
Crossref
Crossref
Donata Favretto, Giulia Stocchero, Susanna Vogliardi, Giampietro Frison, Daniele Trevisanuto, Franca Castagna & Santo Davide Ferrara. (2010) Neonatal Hair Analysis by Liquid Chromatography-High-Resolution Mass Spectrometry to Reveal Gestational Exposure to Venlafaxine. Therapeutic Drug Monitoring 32:1, pages 30-39.
Crossref
Crossref
Marta Concheiro, Hendre? Jones, Rolley E. Johnson, Diaa M. Shakleya & Marilyn A. Huestis. (2010) Confirmatory analysis of buprenorphine, norbuprenorphine, and glucuronide metabolites in plasma by LCMSMS. Application to umbilical cord plasma from buprenorphine-maintained pregnant women. Journal of Chromatography B 878:1, pages 13-20.
Crossref
Crossref
Gary M ReisfieldBruce A Goldberger & Roger L Bertholf. (2009) ‘False-positive’ and ‘false-negative’ test results in clinical urine drug testing. Bioanalysis 1:5, pages 937-952.
Crossref
Crossref
Marinella De Leo, Mario Giorgi, Giuseppe Saccomanni, Clementina Manera & Alessandra Braca. (2009) Evaluation of tramadol and its main metabolites in horse plasma by high-performance liquid chromatography/fluorescence and liquid chromatography/electrospray ionization tandem mass spectrometry techniques. Rapid Communications in Mass Spectrometry 23:2, pages 228-236.
Crossref
Crossref
Elizabeth J Fox, Shirley Twigger & Keith R Allen. (2009) Criteria for opiate identification using liquid chromatography linked to tandem mass spectrometry: problems in routine practice. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 46:1, pages 50-57.
Crossref
Crossref
François-Ludovic Sauvage, Jean-Michel Gaulier, Gérard Lachâtre & Pierre Marquet. (2008) Pitfalls and Prevention Strategies for Liquid Chromatography-Tandem Mass Spectrometry in the Selected Reaction– Monitoring Mode for Drug Analysis. Clinical Chemistry 54:9, pages 1519-1527.
Crossref
Crossref
Uta Kuepper, Frank Musshoff & Burkhard Madea. (2008) Succinylmonocholine analytics as an example for selectivity problems in high-performance liquid chromatography/tandem mass spectrometry, and resulting implications for analytical toxicology. Rapid Communications in Mass Spectrometry 22:12, pages 1965-1970.
Crossref
Crossref
M. Andersson, E. Gustavsson, N. Stephanson & O. Beck. (2008) Direct injection LC?MS/MS method for identification and quantification of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in urine drug testing. Journal of Chromatography B 861:1, pages 22-28.
Crossref
Crossref
E. Raes, A. Verstraete & R. Wennig. 2008. Forensic Science. Forensic Science
611
651
.
Wolfgang Bicker, Michael Lämmerhofer & Wolfgang Lindner. (2007) Mixed-mode stationary phases as a complementary selectivity concept in liquid chromatography–tandem mass spectrometry-based bioanalytical assays. Analytical and Bioanalytical Chemistry 390:1, pages 263-266.
Crossref
Crossref
Hans H. Maurer. (2007) Current role of liquid chromatography–mass spectrometry in clinical and forensic toxicology. Analytical and Bioanalytical Chemistry 388:7, pages 1315-1325.
Crossref
Crossref
Franck Saint-Marcoux, François-Ludovic Sauvage & Pierre Marquet. (2007) Current role of LC-MS in therapeutic drug monitoring. Analytical and Bioanalytical Chemistry 388:7, pages 1327-1349.
Crossref
Crossref
T. A. Brettell, J. M. Butler & J. R. Almirall. (2007) Forensic Science. Analytical Chemistry 79:12, pages 4365-4384.
Crossref
Crossref
. (2006) Current literature in mass spectrometry. Journal of Mass Spectrometry 41:12, pages 1654-1665.
Crossref
Crossref